SightfileU.S. market data from official filings

STEVANATO GROUP S P A (STVN)

Name: STEVANATO GROUP S P A (STVN) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001849853 · EDGAR filings · Updated 2026-06-26

STEVANATO GROUP S P A (STVN) has reported institutional ownership of 14.7%, with 134 institutional managers holding positions valued at $612.7M per the latest 13F reporting period.

Institutional ownership

14.7%

Institutional managers

134

Reported 13F value

$612.7M

Latest updates

2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, STEVANATO GROUP S P A has 134 institutional holders and institutional ownership of 14.7%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 11 reporting insiders, with a net reported value of $0.

Related companies

ARBUTUS BIOPHARMA CORP (ABUS) · AKTIS ONCOLOGY INC (AKTS) · REPLIMUNE GROUP INC (REPL) · XERIS BIOPHARMA HOLDINGS INC (XERS) · OMADA HEALTH INC (OMDA) · BIOAGE LABS INC (BIOA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.